Advances in Using CAR-T cell Therapy to Treat HIV

In by

Spotlight Article

Interview

Scott G Kitchen

Latest Advances in CAR-T Cell Manufacture & Clinical Developments

Dr. Scott G Kitchen’s research interests are focused on investigating the effects of viral infection, as well as other cellular abnormalities, on human hematopoiesis and on exploring ways to correct defects that exist in immunity to viral and cellular antigens. Dr. Kitchen’s laboratory is interested in understanding the mechanisms that limit the immune systems’ ability to clear infection or cancer and in developing ways that augment these responses. They are also interested in developing gene therapy-based approaches to engineer human hematopoietic stem cells to reconstitute and/or enhance immune responses following their development into mature cells that specifically target HIV infection as well as other viral and cellular antigens. In addition, his laboratory is interested in the development of mouse/human chimeric models that allow the characterization of human hematopoiesis and engineered immunity in a surrogate in vivo host.

DOI: 10.18609/cgti.2018.034
Citation: Cell Gene Therapy Insights 2018; 4(4), 357-362.
Open access

This content is restricted to registered users. Click here to Register or Login here.